Cargando…

Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [(124)I]FIAU PET/CT

PURPOSE: Imaging is limited in the evaluation of bacterial infection. Direct imaging of in situ bacteria holds promise for noninvasive diagnosis. We investigated the ability of a bacterial thymidine kinase inhibitor ([(124)I]FIAU) to image pulmonary and musculoskeletal infections. METHODS: Thirty-th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Steve Y., Rowe, Steven P., Jain, Sanjay K., Schon, Lew C., Yung, Rex C., Nayfeh, Tariq A., Bingham, Clifton O., Foss, Catherine A., Nimmagadda, Sridhar, Pomper, Martin G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325456/ https://www.ncbi.nlm.nih.gov/pubmed/32598214 http://dx.doi.org/10.1177/1536012120936876

Ejemplares similares

Imaging of Musculoskeletal Bacterial Infections by [(124)I]FIAU-PET/CT
por: Diaz, Luis A., et al.
Publicado: (2007)

(64)Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2014)

Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals
por: Davis, Stephanie L., et al.
Publicado: (2009)

Non-invasive PD-L1 quantification using [(18)F]DK222-PET imaging in cancer immunotherapy
por: Mishra, Akhilesh, et al.
Publicado: (2023)

Development of [(18)F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
por: Lesniak, Wojciech G., et al.
Publicado: (2019)

Peptide-Based (68)Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
por: De Silva, Ravindra A., et al.
Publicado: (2018)

First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
por: Zhou, Xin, et al.
Publicado: (2022)

Iodine-124: A Promising Positron Emitter for Organic PET Chemistry
por: Koehler, Lena, et al.
Publicado: (2010)

[(64)Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
por: Minn, Il, et al.
Publicado: (2016)

Quantitative performance of (124)I PET/MR of neck lesions in thyroid cancer patients using (124)I PET/CT as reference
por: Jentzen, Walter, et al.
Publicado: (2018)

Gallium-68–labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics
por: Mishra, Akhilesh, et al.
Publicado: (2023)

Quantitative imaging of (124)I and (86)Y with PET
por: Lubberink, Mark, et al.
Publicado: (2011)

Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging
por: Nimmagadda, Sridhar
Publicado: (2012)

Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and Challenges
por: Nimmagadda, Sridhar
Publicado: (2020)

PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
por: Du, Yong, et al.
Publicado: (2020)

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts
por: Azad, Babak Behnam, et al.
Publicado: (2016)

Intra-Individual Comparison of (124)I-PET/CT and (124)I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma: Aspects of Attenuation Correction
por: Grafe, Hong, et al.
Publicado: (2022)

The next era of renal radionuclide imaging: novel PET radiotracers
por: Werner, Rudolf A., et al.
Publicado: (2019)

Uptake of [(18)F]DCFPyL in Paget's Disease of Bone, an Important Potential Pitfall in the Clinical Interpretation of PSMA PET Studies
por: Rowe, Steven P., et al.
Publicado: (2015)

The diagnostic value of (124)I-PET in patients with differentiated thyroid cancer
por: Phan, Ha T. T., et al.
Publicado: (2008)

Comparison of Imaging Characteristics of (124)I PET for Determination of Optimal Energy Window on the Siemens Inveon PET
por: Yu, A Ram, et al.
Publicado: (2016)

A Robust Approach to Enhance Tumor-selective Accumulation of Nanoparticles
por: Qiao, Yuan, et al.
Publicado: (2011)

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
por: Krishnamachary, Balaji, et al.
Publicado: (2012)

A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
por: Chatterjee, Samit, et al.
Publicado: (2016)

Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with (124)I
por: Kist, Jakob W., et al.
Publicado: (2016)

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Imaging of carbonic anhydrase IX with an (111)In-labeled dual-motif inhibitor
por: Yang, Xing, et al.
Publicado: (2015)

Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Musculoskeletal pitfalls in (68)Ga-PSMA PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)

Is the Image Quality of I-124-PET Impaired by an Automatic Correction of Prompt Gammas?
por: Preylowski, Veronika, et al.
Publicado: (2013)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry
por: Zlitni, Aimen, et al.
Publicado: (2017)

Radiosynthesis of no-carrier-added meta-[(124)I]iodobenzylguanidine for PET imaging of metastatic neuroblastoma
por: Green, Michael, et al.
Publicado: (2016)

Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124
por: Kersting, David, et al.
Publicado: (2021)

Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA
por: Miederer, Matthias, et al.
Publicado: (2021)

Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124
por: Kumar, Krishan, et al.
Publicado: (2021)

Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood–brain barrier through paracellular transmigration and ERK activation
por: Sagar, Divya, et al.
Publicado: (2012)

Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for Localizing Recurrence in Patients with Differentiated Thyroid Carcinoma
por: Lee, Jandee, et al.
Publicado: (2012)

Pilot study of PET imaging of (124)I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer
por: O’Donoghue, Joseph A, et al.
Publicado: (2013)

Optimizing reconstruction parameters for quantitative (124)I-PET in the presence of therapeutic doses of (131)I
por: Fanchon, Louise M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mio6u854mrik9ehnu9l0a4otg9